Katherine L. Nathanson, MD

Dr. Nikhil Jiwrajka, MD, is an Instructor of Medicine in the Division of Rheumatology at the University of Pennsylvania’s Perelman School of Medicine. He earned his MD from Johns Hopkins University School of Medicine and completed both his Internal Medicine residency and Rheumatology fellowship training at the Hospital of the University of Pennsylvania. Dr. Jiwrajka specializes in caring for individuals with scleroderma, autoimmune interstitial lung disease (“ILD”), myositis-associated lung disease, and related autoimmune diseases. His research, conducted in the lab of Dr. Montserrat Anguera, focuses on understanding why scleroderma and related autoimmune diseases preferentially afflict females, with the hope that this understanding can help inform the development of new diagnostics and treatments for patients with these diseases.

Dr. Rose is double board-certified in general surgery and plastic surgery. Her primary clinical interests include breast reconstruction and microsurgery though she also performs a variety of other plastic surgery cases.She has authored many peer-reviewed publications and book chapters on breast reconstruction, microsurgery and other topics and made presentations at both national and regional conferences.

The Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania is dedicated to advancing research that bridges the gap between basic science and clinical applications, focusing on the development of new and safer medicines. With an extensive network of over 2,500 investigators and partnerships with the Children's Hospital of Philadelphia and other notable institutions, ITMAT supports a comprehensive training platform for both researchers and support staff involved in translational medicine. Since its inception in January 2005, ITMAT has propelled the field of human phenomic science and enhanced collaborative interdisciplinary research through various funding initiatives and educational programs. The institute emphasizes bridging the pediatric to adult healthcare divide and integrates preclinical science with practical drug development, enriching the landscape of translational therapeutics. Generated from the website